Compare Moderna, Inc. (MRNA) vs Royal Bank of Canada (RY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Moderna, Inc. vs Royal Bank of Canada — how do they compare? Moderna, Inc. trades at $59.68 (market cap $23.60B), while Royal Bank of Canada trades at $210.37 (market cap $289.51B). The key difference: Royal Bank of Canada is far larger — about 12.3× Moderna, Inc.'s market cap, and Royal Bank of Canada pays a 2.42% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.
| MRNA | RY | |
|---|---|---|
Market Cap | $23.60B | $289.51B |
Sector | Health | Financials |
52-Week High | $81.80 | $217.87 |
52-Week Low | $22.36 | $128.46 |
Enterprise Value | $19.70B | — |
Dividend Yield | — | 2.42% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →About Royal Bank of Canada
Royal Bank of Canada is one of the two largest banks in Canada. It is a diversified financial services company, offering personal and commercial banking, wealth-management services, insurance, corporate banking, and capital markets services. The bank is concentrated in Canada, with additional operations in the U.S. and other countries.
Read more on RY →
